From: Microbiota and neurologic diseases: potential effects of probiotics
Authors | Study design | Main neurologic results |
---|---|---|
Messaoudi et al. [97] | Double-blind, placebo-controlled, randomized trial on healthy volunteers treated with the oral administration of L. helveticus R0052 and B. longum R0175 vs. placebo for 30 days | Reduced psychological distress and urinary free-cortisol level in probiotics arm |
Tillisch et al. [98] | Randomized controlled clinical trial on healthy women treated with fermented milk containing B. animalis subsp. lactis, S. thermophiles, L. bulgaricus and L. lactis subsp. lactis vs placebo for 4 weeks | Reduction in responsiveness to negative emotional stimulations in probiotics arm |
Matsuzaki et al. [99] | Prospective, uncontrolled treatment with L. casei strain Shirota for 4 weeks in patients suffering HTLV-1 associated myelopathy/tropical spastic paraparesis | Improvement in motor dysfunction, urinary symptoms and spasticity in lower extremities |
Rao et al. [100] | Double-blind, placebo-controlled, randomized trial in patients with chronic fatigue syndrome treated with L. casei strain Shirota vs placebo for 2 months | Decrease in anxiety symptoms in probiotic arm |